ABOUT VAXDYN

Vaxdyn is a biotechnology company located in Seville, Spain that specializes in the discovery and development of antigens, immunomodulators, nanoparticles and mAbs for infectious diseases.

Company History

Vaxdyn was founded on 2011 by researchers working in the Infectious Disease Service at the University Hospital Virgen del Rocio in Seville, Spain in order to commercialize promising technology that was being developed in their research laboratories.
Since the foundation, there have been important advances on the candidate’s research, legal contracts, patents registration, business networking and financial matters.

Company Location and Facilities

As a spin-off resulting from work developed in the Biomedical Research Institute of Seville at the Hospital Virgen del Rocío. Vaxdyn has the opportunity to access space in the Biomedical Research Institute of Seville. The Biomedical Research Institute of Seville is a state-of-the-art research complex formed in collaboration between the Hospital Virgen del Rocío, the University of Seville and the Consejo Superior de Investigaciones Científicas (CSIC).

Laboratory facilities

  • Laboratory space suitable for antigen design
  • Characterization and purification
  • Animal facilty suitable for proof-of-concept studies
  • Core facilities (flow cytometry, imaging systems, etc.)

Clinical facilities

    • Clinical Unit capable of carrying out
    • Phase I clinical trails

Administrative Offices

    • 20 m² fully equipped office

Our Team

Vaxdyn’s management team includes members with both scientific and business expertise.

Juan José Infante
Juan José InfanteCEO & Founder
Dr. Infante Viñolo has served as CEO of Vaxdyn since November 2013. He obtained his Ph.D. in Chemistry with specialization in Microbiology and Biochemistry from the University of Cádiz in Spain. He has 4 years of postdoctoral experience at the University of Washington Medical School in Seattle, USA. After his postdoctoral experience, he served as CSO of Bionaturis, a biotechnology company specialized in biological drug development and manufacturing for human and animal health.
Juan Domínguez
Juan DomínguezProject Manager & Service Manager
Dr. Domínguez Herrera is the Project Manager & Service Manager of Vaxdyn since July 2014. He obtained his B.S. degree in Biology and his Ph.D. in Biomedicine from the University of Seville in Spain. His previous work has included the development of several projects focused on developing new therapeutic alternatives against multidrug resistant pathogen. He has 7 years of experience in the development of experimental models of infection and resistant mechanisms of bacteria.
Michael McConnell
Michael McConnellChief Scientific Officer
Dr. McConnell is currently an investigator in the Institute for Biomedical Research in Seville as part of the Infectious Disease Service at the University Hospital Virgen del Rocío. He obtained his B.S. degree in Biochemistry from the University of Notre Dame in the United States.

He subsequently obtained his M.D. and Ph.D. in Microbiology and Immunology from the University of Michigan, United States.

He has eight years of experience in the vaccine development field. His previous work has included the development of a vaccine for rapid vaccination against anthrax at the University of Michigan Medical School.

He currently is the lead investigator in the development of a vaccine for Acinetobacter baumannii at the University Hospital Virgen del Rocío.

Pilar Pérez Romero
Pilar Pérez RomeroChair Board of Directors
Dra. Pérez-Romero is the principal investigator of the Virology Research Laboratory in the Infectious Disease Service at the University Hospital Virgen del Rocío. She obtained her B.S. degree in Biology and her Ph.D. in Microbiology from the University of Seville in Spain.

Her previous work has focused on the characterization of viral infections and their immune response. She is a member of the Spanish Network for AIDS Investigation, the European Society for Clinical Microbiology and Infectious Diseases and the American Society for Virology.

She has directed numerous research projects in her laborator

Jerónimo Pachón
Jerónimo PachónScientific Advisory Board
Dr. Pachón is currently the Principal Investigator of the Infectious Diseases research group at the Institute of Biomedicine of Seville (IBiS). He has worked in the area of antimicrobial resistance for more than 20 years during which he has led numerous projects investigating bacterial infections. He obtained his M.D. and Ph.D. from the University of Seville in Spain. He has over 35 years of clinical experience and has participated in the design and analysis of numerous clinical trials. Furthermore, Dr. Pachón is a member of the Infectious Diseases Service of University Hospital Virgen del Rocío in Seville and Professor of Medicine at the University of Seville.